全文获取类型
收费全文 | 1380篇 |
免费 | 79篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 81篇 |
妇产科学 | 7篇 |
基础医学 | 119篇 |
口腔科学 | 17篇 |
临床医学 | 185篇 |
内科学 | 305篇 |
皮肤病学 | 22篇 |
神经病学 | 155篇 |
特种医学 | 259篇 |
外科学 | 112篇 |
综合类 | 36篇 |
预防医学 | 51篇 |
眼科学 | 32篇 |
药学 | 68篇 |
中国医学 | 2篇 |
肿瘤学 | 65篇 |
出版年
2021年 | 13篇 |
2020年 | 8篇 |
2019年 | 9篇 |
2018年 | 19篇 |
2017年 | 9篇 |
2015年 | 19篇 |
2014年 | 28篇 |
2013年 | 38篇 |
2012年 | 32篇 |
2011年 | 39篇 |
2010年 | 37篇 |
2009年 | 36篇 |
2008年 | 27篇 |
2007年 | 80篇 |
2006年 | 44篇 |
2005年 | 42篇 |
2004年 | 30篇 |
2003年 | 23篇 |
2002年 | 32篇 |
2001年 | 33篇 |
2000年 | 30篇 |
1999年 | 34篇 |
1998年 | 59篇 |
1997年 | 37篇 |
1996年 | 66篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 55篇 |
1992年 | 31篇 |
1991年 | 32篇 |
1990年 | 34篇 |
1989年 | 41篇 |
1988年 | 48篇 |
1987年 | 47篇 |
1986年 | 38篇 |
1985年 | 35篇 |
1984年 | 22篇 |
1983年 | 13篇 |
1982年 | 13篇 |
1981年 | 22篇 |
1980年 | 22篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 20篇 |
1976年 | 13篇 |
1975年 | 15篇 |
1971年 | 5篇 |
1970年 | 9篇 |
1967年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有1518条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Although a significant interaction between cyclosporine and amphotericin-B (AmpB) has been observed clinically, these findings have not been duplicated in animal studies. A total of 64 male albino rats were used in single- and multiple-dose experiments with AmpB and CsA in the absence or presence of systemic Candida infection. No significant differences in glomerular filtration rate were found in rats given single i.v. doses of AmpB 1 mg/kg compared with AmpB and CsA. Furthermore, rats given i.p. AmpB 1 mg/kg and CsA 10 mg/kg daily for 10 days showed no significant differences in GFR compared with animals given CsA alone. Morphology and CsA whole-blood pharmacokinetics were not different between groups administered single-dose CsA, AmpB, or the combination; similarities also existed with multiple-dose studies. In an attempt to mimic the clinical setting, 2 groups of rats were administered i.p. CsA 10 mg/kg/day for 10 days followed by inoculation of Candida albicans. After 48 hr, a single i.v. dose of AmpB 1.0 mg/kg was associated with a 33% decline in GFR compared with those given sterile water (P less than 0.05). Systemic clearance of CsA was markedly reduced in candidiasis rats administered AmpB compared with controls given sterile water. A significant reduction in renal Candida colony-forming units was found in rats given CsA and AmpB compared with those administered CsA alone. These data suggest that the presence of systemic Candida highlights the interaction of CsA and AmpB in the rat model. 相似文献
6.
Machado-Joseph disease is a dominantly inherited, multisystem, degenerative disorder that lacks a proven genetic marker. Peripheral nerve conduction-refractory period, sensory evoked potentials, and quantified oculomotor recordings were studied in nine patients affected with this disease to look for a potential physiologic marker. Only the oculomotor measurements of saccade and smooth pursuit gain were consistently abnormal in all patients. Identical eye movement recordings in 12 asymptomatic individuals at risk for Machado-Joseph disease revealed findings typical of affected patients in only 1 individual. Quantified oculomotor studies may contribute to the early confirmation of the disease, primarily in individuals at risk with minor or equivocal neurologic signs. 相似文献
7.
8.
R. Grant Steen Suzanne A. Gronemeyer Peter B. Kingsley Wilbum E. Reddick James S. Langston June S. Taylor 《Journal of magnetic resonance imaging : JMRI》1994,4(5):681-691
Precise and accurate inversion-recovery (PAIR) magnetic resonance (MR) measurements of T1 were obtained in eight brain regions and cerebrospinal fluid of 26 healthy volunteers. Accuracy of the technique was assessed by measuring T1 in small fluid volumes with the PAIR technique and with two independent spectroscopic techniques. The mean difference between T1 measured with PAIR and with the two spectroscopic techniques was 3.1% ± 1.3. The precision (reproducibility) of measurements with the PAIR technique was excellent. The coefficient of variation (CV) across 16 measurements in a head phantom was 2.0%, compared with a CV of 2.7% across 45 separate measurements in a single subject. The within-subject CV was 1.8% ± 0.6 in white matter and 1.4% ± 1.0 in basal ganglia. The between-subject CV in 26 healthy volunteers was 3.6% ± 0.6 in white matter and 4.1% ± 1.9 in basal ganglia. Comparison between a patient with an active recurrent brain tumor and an agematched patient with an inactive brain tumor showed that T1 was significantly elevated throughout the brain of the active-tumor patient, especially in white matter tracts, even though no tumor or edema was detected in the white matter on standard MR images. Comparisons between five brain tumor patients and four healthy volunteers of similar age showed that T1 was significantly and substantially elevated throughout the white matter tracts and in the caudate nucleus, putamen, and thalamus. These results are consistent with the hypothesis that white matter tracts are selectively vulnerable to edema and that T1 increases in white matter are a sensitive indicator of patient status or tumor aggressiveness. 相似文献
9.
Modulating role of dopamine on anesthetic requirements 总被引:6,自引:0,他引:6
I S Segal J K Walton I Irwin L E DeLanney G A Ricaurte J W Langston M Maze 《European journal of pharmacology》1990,186(1):9-15
The influence of dopamine on halothane anesthetic requirements was determined in mice. Halothane anesthetic requirement was defined as the minimum anesthetic concentration (MAC) that prevented 50% animals from moving in response to a supramaximal stimulus. Levodopa (L-DOPA) dose-dependently decreased halothane MAC to a maximum of 49% of control; over the same dose range L-DOPA increased striatal dopamine nearly 4-fold. The MAC-reducing effect of L-DOPA was attenuated by selective antagonism of the D2 dopamine receptor with YM-09151-2 while selective blockade of the D1 dopamine receptor with SCH-23390 did not alter L-DOPA's effect on the MAC for halothane. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreased striatal dopamine by 82% and increased the MAC for halothane by 27%. Repletion of striatal dopamine with L-DOPA, in MPTP-treated mice, restored the MAC for halothane back to the control state. The regression line derived from the plot of halothane MAC versus striatal dopamine content shows a highly significant correlation between the two variables (r2 = 0.94). These are the first results to suggest that anesthetic requirements can be modulated directly and precisely by increasing or decreasing the content of a single neurotransmitter in the central nervous system. 相似文献
10.
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B 总被引:2,自引:0,他引:2
K T Finnegan J J Skratt I Irwin L E DeLanney J W Langston 《European journal of pharmacology》1990,184(1):119-126
Clinical studies suggest that deprenyl may retard the progression of Parkinson's disease, an effect that may be related to its monoamine oxidase (MAO) inhibiting properties. Deprenyl also protects against the neurodegenerative effects of the noradrenergic toxin DSP-4. In this study we investigated the role of MAO B inhibition in this protection. C57BL/6 mice were given DSP-4 (50 mg/kg i.p.) 1 h. 24 h or 4 days after the administration of deprenyl (10 mg/kg i.p.) or the selective MAO B inhibitor MDL 72974 (1.25 mg/kg), and then killed 1 week later for assay of hippocampal norepinephrine. The MAO B inhibiting effects of deprenyl or MDL 72974 were also determined after these same intervals of time. Deprenyl and MDL 72974 produced comparable degrees of enzyme inhibition 1 h (greater than 95%), 24 h (greater than 90%) or 4 days (greater than 70%) after their administration. Given 1 h before, deprenyl totally blocked the norepinephrine-depleting effects of DSP-4, but this protection declined sharply when 24 h or 4 days was allowed to elapse between deprenyl and DSP-4 administration. MDL 72974 failed to protect at any time point. In vitro, we detected no activity using DSP-4 as a substrate for MAO. These findings suggest that the ability of deprenyl to protect against DSP-4-induced neuronal degeneration may not depend on its MAO B inhibiting properties. 相似文献